Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP analogs for treating contrast-induced nephropathy

Use of pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP analogs for treating contrast-induced nephropathy

US Patent 9353171 · Granted May 31, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diarylamide compound and application thereof2025
Conjugates, their compositions, and their related methods2025
Solid pharmaceutical composition comprising TLR7 agonist2025
Personal care compositions2025
Dipeptide compounds and uses thereof2025
Personal care compositions2025
Personal care compositions for treating odor causing bacteria and methods for th2025
Personal care compositions2024
Reactive dyes and preparation methods thereof2024
Pregabalin lactam methylene dimer and preparation method therefor2024
Integrated selective capture, sequestration, fluidic isolation, electrical lysis2023
N-formyl vortioxetine and preparation method thereof and solid preparation of vo2023